People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acutus Medical, Inc. | — | Healthtech | Series D+ | $296.3M | $69.0M | 2022 |
David Roman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Roman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Johnson | 1 | 12 |
| Steven Hochberg | 1 | 9 |
| Scott Huennekens | 1 | 7 |
| Andrew ElBardissi | 1 | 7 |
| David Bonita | 1 | 6 |
| Aditya Puri | 1 | 4 |
| John Onopchenko | 1 | 4 |
| Shahzad Malik | 1 | 4 |
| Vince Burgess | 1 | 3 |
| Shaden Marzouk | 1 | 2 |
| Randy Werneth | 1 | 2 |
| John Sheridan | 1 | 2 |
| Jim Hinrichs | 1 | 2 |
| Niamh Pellegrini | 1 | 2 |
| Gary Doherty | 1 | 1 |
| Andrew El Bardissi | 1 | 1 |
| Bert Van Meurs | 1 | 1 |
| Graydon Beatty | 1 | 1 |
| John Dahldorf | 1 | 1 |
| Christoph Scharf | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.